[PDF] Top 20 Ejercicios de Actuación Para El Taller de Teatro
Has 10000 "Ejercicios de Actuación Para El Taller de Teatro" found on our website. Below are the top 20 most common "Ejercicios de Actuación Para El Taller de Teatro".
Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer’s disease cohort
... for functional impairment among the elderly, even after adjusting for socio-demographic and medical cha- racteristics ...positive response in ...the functional benefit of the drug com- pared with the ... See full document
37
A longitudinal study of risk factors for community-based home help services in Alzheimer’s disease: the influence of cholinesterase inhibitor therapy
... medications at baseline are related to a smaller volume of HHS are alarming. The social service system may be more focused on functional capacity than on cognitive ability because deficiencies in ADL are more ... See full document
11
Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy
... and functional outcomes according to the stages of AD, and in new ther- apies aimed at blocking the course of the disease especially in the early ...a cohort of pa- tients with both mild and moderate ... See full document
30
Hippocampal atrophy but not white-matter changes predicts the long-term cognitive response to cholinesterase inhibitors in Alzheimer’s disease
... and response to ChEI therapy for AD patients remains controversial ...ChEI therapy for six months ...or functional outcome after ChEI therapy for three months [4], one year [28], or ... See full document
79
SYNERGIC TRIAL (SYNchronizing Exercises, Remedies in Gait and Cognition) a multi-Centre randomized controlled double blind trial to improve gait and cognition in mild cognitive impairment
... Gait performance will be recorded using electronic walkway systems which automatically determine spatio- temporal gait parameters from imbedded sensors acti- vated by foot pressure [36]. The gait mat will be located in a ... See full document
16
Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer’s Coordinating Center Uniform Data Set
... For neuropsychological tests, baseline volume of WMH had the strongest effects for accelerated decline on measures that assess cognitive flexibility (TMT-B), working memory and information processing speed (WAIS-R DSC), ... See full document
10
Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE)
... mild Alzheimer ’ s dementia patients, first-degree relatives of patients with Alzheimer ’ s dementia, and cognitively unimpaired control subjects are ... See full document
13
Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment
... For comparison of demographic and clinical variables be- tween groups with and without progression to dementia, we used the Pearson chi-squared test, Mann–Whitney test, or Student’s t test as appropriate. We assessed the ... See full document
6
Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
... The study protocol was approved by the ethics commit- tee of the university clinic Erlangen-Nürnberg (number 3987), and all participants provided written informed consent. The patients were recruited in the memory clinic ... See full document
8
Alzheimer’s Disease Assessment Scale–Cognitive subscale variants in mild cognitive impairment and mild Alzheimer’s disease: change over time and the effect of enrichment strategies
... For the past two decades, the 11-item Alzheimer’s Dis- ease Assessment Scale–Cognitive subscale (ADAS-Cog 11) has been a nearly ubiquitous measure of cognition in clinical trials of putative new therapies for Alzheimer’s ... See full document
55
Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort
... and disease mechanisms of Alzheimer ’ s disease and related disorders (ADRD) are still poorly ...MEMENTO cohort study, participants were recruited in memory clinics and screened for ... See full document
24
Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment
... CHARTER cohort), which by definition precluded an assessment of the contribution of HIV in- fection to their neurocognitive impairment, were not eli- gible for a diagnosis of HAND according to Frascati criteria ... See full document
6
Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal
... Individuals with mild cognitive impairment (MCI) are at in- creased risk to develop dementia. 1 Yet, up to 25% of individuals with MCI revert to normal cognition (NC). 2,3 Although im- proved cognition seems to be a ... See full document
6
Cognitive reserve and clinical progression in Alzheimer diseaseA paradoxical relationship
... In the present study we investigated how CR, defined as the degree to which an individual’s observed cerebral damage was higher or lower than predicted from cognitive performance, affected clinical progression in AD. In an ... See full document
7
Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease
... for Alzheimer ’ s disease (AD) have no effect on disease progression, and this creates a large unmet medical ...antibody response to the vaccine demonstrated reduced cognitive decline, ... See full document
88
Psychosocial interventions for Alzheimer’s disease cognitive symptoms: a Bayesian network meta-analysis
... from functional deterioration by slowing progressive decline showed the best efficacy for cognitive impairments in AD ...bined therapy, rather than only using ... See full document
5
Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review
... function at work or in usual daily activities [86]. There- fore, the identification of IADL deficits in MCI as an early phase of AD is absolutely essential for clinical prac- tice. Regarding the effect sizes, the ... See full document
24
Dominantly Inherited Alzheimer Network: facilitating research and clinical trials
... proposed disease- modifying drugs in phase II or phase III trials could be due to limitations of translating animal results into hu- man disease, or the drugs may have been administered too late in the ... See full document
12
Prevalence of abnormal Alzheimer’s disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples
... for Alzheimer ’ s disease (AD) will be most effective when applied to individuals in a disease stage prior to mild cognitive impairment (MCI) or prodromal AD [1, ... See full document
11
Continuation versus discontinuation of treatment for severe dementia: randomized, pragmatic, open-label, clinical trial to evaluate the efficacy of continuing drug treatment in patients with severe dementia (STOP-DEM)
... dementia, Alzheimer ’ s disease, with or without a coexisting diagnosis of vascular dementia, and a score of 10 or less on the Mini-Mental State Examination who received previous treatment with a ... See full document
5
Related subjects